Evidence map›Paper›PMID 34208954›Full record

ArticleViruses2021

Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders.

Maria de Lourdes Benamor Teixeira, Orlando da Costa Ferreira Júnior, Esaú João, Trevon Fuller, Juliana Silva Esteves, Wallace Mendes-Silva, Carolina Carvalho Mocarzel, Richard Araújo Maia, Lídia Theodoro Boullosa, Cássia Cristina Alves Gonçalves and 2 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Coagulation conundrum in obstetric anesthesia with COVID-19.Medical journal, Armed Forces India · 2022
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Maria de Lourdes Benamor TeixeiraInfectious Diseases Department, Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Anexo IV 4° Andar, Rio de Janeiro 20221-161, RJ, Brazil.ORCID 0000-0002-6896-0089
Orlando da Costa Ferreira JúniorLaboratório de Biologia Molecular, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373-Sala A1-050-Cidade Universitária da Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
Esaú JoãoInfectious Diseases Department, Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Anexo IV 4° Andar, Rio de Janeiro 20221-161, RJ, Brazil.ORCID 0000-0002-2412-0627
Trevon FullerInfectious Diseases Department, Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Anexo IV 4° Andar, Rio de Janeiro 20221-161, RJ, Brazil.
Juliana Silva EstevesMaternal Fetal Department and Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Rio de Janeiro 20221-161, RJ, Brazil.
Wallace Mendes-SilvaMaternal Fetal Department and Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Rio de Janeiro 20221-161, RJ, Brazil.
Carolina Carvalho MocarzelMaternal Fetal Department and Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Rio de Janeiro 20221-161, RJ, Brazil.
Richard Araújo MaiaLaboratório de Biologia Molecular, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373-Sala A1-050-Cidade Universitária da Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
Lídia Theodoro BoullosaLaboratório de Biologia Molecular, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373-Sala A1-050-Cidade Universitária da Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
Cássia Cristina Alves GonçalvesLaboratório de Biologia Molecular, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373-Sala A1-050-Cidade Universitária da Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
Patrícia Pontes FrankelMaternal Fetal Department and Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Rio de Janeiro 20221-161, RJ, Brazil.
Maria Isabel Fragoso da Silveira GouvêaInfectious Diseases Department, Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Anexo IV 4° Andar, Rio de Janeiro 20221-161, RJ, Brazil.
Hospital Federal dos Servidores do Estado · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are some reports and case series addressing Coronavirus Disease 2019 (COVID-19) infections during pregnancy in upper income countries, but there are few data on pregnant women with comorbid conditions in low and middle income Countries. This study evaluated the proportion and the maternal and neonatal outcomes associated with SARS-CoV-2 infection among pregnant women with comorbidities. Participants were recruited consecutively in order of admission to a maternity for pregnant women with comorbidities. Sociodemographic, clinical, and laboratory data were prospectively collected during hospitalization. Pregnant women were screened at entry: nasopharyngeal swabs were tested by RT-PCR; serum samples were tested for IgG antibodies against spike protein by ELISA. From April to June 2020, 115 eligible women were included in the study. The proportion of SARS-CoV-2 infection was 28.7%. The rate of obesity was 60.9%, vascular hypertension 40.0%, and HIV 21.7%. The most common clinical presentations were ageusia (21.2%), anosmia (18.2%), and fever (18.2%). Prematurity was higher among mothers who had a SARS-CoV-2 infection based on RT-PCR. There were two cases of fetal demise. We found a high proportion of COVID-19 among pregnant women with comorbidities. This underscores the importance of antenatal care during the pandemic to implement universal SARS-CoV-2 screening, precautionary measures, and the rollout of vaccination programs for pregnant women.

Indexed as

AdultCohort StudiesComorbidityCOVID-19FemaleHospitalizationHumansImmunoglobulin GInfant, NewbornInfectious Disease Transmission, VerticalObesityPilot ProjectsPregnancyPregnancy Complications, InfectiousPregnant PeopleSARS-CoV-2Immunoglobulin GHIVobesityobstetricspregnancySARS-CoV-2

Identifiers

PMID34208954
PMCPMC8310251
OpenAlexW3173969609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.